Biopsys Medical, Inc. Announces Distribution Agreement.IRVINE, Calif.--(BUSINESS WIRE)--July 8, 1996--Biopsys Medical, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BIOP BIOP Baghdad International Airport BIOP Broadcast Inter-ORB Protocol BIOP Burst Idle Optical Protocol BIOP Basis of Issue Plan BIOP Bureau d'Information et d'Orientation Professionnelles (French) ) announced today that it has entered into a non-exclusive agreement with LORAD LORAD Long Range Active Detection (sonar system) LORAD Long Range Air Defense , a Division of Trex Medical Corp., for the distribution of the Mammotome Biopsy System. Under the terms of the agreement, Lorad dealers may purchase the Mammotome motor drive unit directly from Biopsys at a discount from list price and bundle the Mammotome motor drive unit as part of the sale of a Lorad stereotactic stereotactic /ster·eo·tac·tic/ (-tak´tik) 1. characterized by precise positioning in space; said especially of discrete areas of the brain that control specific functions. 2. pertaining to stereotactic surgery. imaging table. Customers will continue to purchase the Mammotome disposable probe directly from Biopsys. Lorad and Fischer Imaging Corp. are the two major suppliers of stereotactic imaging tables in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . Biopsys will continue to operate under a non-exclusive distribution arrangement with Fischer Imaging. Steven L. Gex, President and Chief Executive Officer, stated "This agreement formalizes our existing relationship with Lorad and further demonstrates the acceptance of the Mammotome product in the marketplace." Biopsys Medical, Inc. designs, develops, manufactures and markets products for the diagnosis and management of breast cancer. The company's principal product, the Mammotome Biopsy System, is a less invasive alternative to open surgical biopsy. CONTACT: Biopsys Medical, Inc. Steven J. Naber, 714/460-7800 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion